Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo

Annals of Hematology

Volumn 73, Issue 5, 1996, Pages 231-238

  Aman, M J ^a   Stockdreher, K ^a   Thews, A ^a   Kienast, K ^a   Aulitzky, W E ^a   Farber L ^b   Haus, U ^b   Koci, B ^c   Huber, C ^a   Peschel, C ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Klinische Forschung   (Germany)

^c Amgen Research GmbH   (Germany)

Author keywords

Cytokine production; G CSF; GM CSF; Surface marker expression

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HERMES ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; MESSENGER RNA; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FLOW CYTOMETRY; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MONONUCLEAR CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIGENS, SURFACE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; RNA, MESSENGER; SIALOGLYCOPROTEINS; SOLUBILITY;

EID: 10544228942     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050234     Document Type: Article

References (58)

1. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK (1993) CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669-674
2. Aman MJ, Rudolf G, Goldschmitt J, Aulilzky WE, Lam C, Huber C, Peschel C (1993) Type 1 interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 82:2371-2378
3. Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C (1994) Regulation of cytokine expression by Interferon alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood 83:4142-4150
4. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836
5. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303
6. Aulitzky WE, Aulitzky WK, Frick J, Herold M, Gastl G, Tilg H, Berger M, Huber C (1990) Treatment with recombinant Interferon gamma induces release of endogenous tumor necrosis factor alpha. Immunobiology 180:385-394
7. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77:2316-2321
8. Biesma B, de Vries EGE, Willemse PHB, Sluiter WJ, Postmus PE, Limburg PC, Stern AC, Vellenga E (1990) Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever. Eur J Cancer 26:932-936
9. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
10. Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW (1989) Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 73:694-699
11. Cicco NA, Lindemann A, Content J, Vandenbussche P, Lubbert M, Gauss J, Mertelsmann R, Herrmann F (1990) Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 75:2049-2052
12. Colombo MP, Ferrari G, Stoppacciaro A, Parenza M, Rodolfo M, Mavilio F, Parmiani G (1991) Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173:889-897
13. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med 325:164-170
14. Danis VA, Franic GM, Rathjen DA, Brooks PM (1991) Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin Exp Immunol 85:143-150
15. Demetri GD, Griffen JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78:2791-2808
16. Donahue RE, Emerson SG, Wang EA, Wong GG, Clark SC, Nathan DG (1985) Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin. Blood 66:1479
17. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543
18. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196-2200
19. Gabrilove J (1992) The development of granulocyte colony-stimulating factor in its various clinical applications. Blood 80:1382-1385
20. Ganser A, Volkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. Blood 73:31-37
21. Gasson JC (1991) Molecular physiology of granuloyte-macrophage colony-stimulating factor. Blood 6:1131-1145
22. Gerhartz HH, Engelhard M, Meusers P, Brittinger G, Wilmans W, Schlimok G, Mueller P, Huhn D, Musch R, Siegert W, Gerhartz D, Hartlapp JH, Thiel E, Huber C, Peschel C, Spann W, Emmerich B, Schadek C, Westerhausen M, Pees H-W, Radtke H, Engert A, Terhardt E, Schick H, Binder T, et al (1993) Randomized, double-bind, placebo-controlled, phase-III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant lymphomas. Blood:2329-2339
23. Griffin JD, Spertini O, Ernst TJ, Belvin MP, Levine HB, Kanakura Y, Tedder TF (1990) Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. J Immunol 145:576-584
24. Hansen PB, Kjaersgaard E, Johnsen HE, Gram J, Pedersen M, Nikolajsen K, Hansen NE (1993) Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors. Br J Haematol 85:50-56
25. Hladik F, Tratkiewicz JA, Tilg H, Vogel W, Schwulera U, Kränke M, Aulitzky WE, Huber C (1994) Biologic activity of low dosage IL-2 treatment in vivo: molecular assessment of cytokine network interaction. J Immunol 153:1449-1454
26. Ho AD, Haas R, Wulf G, Knauf W, Ehrhardt R, Heilig B, Korbling M, Schulz G, Hunstein W (1990) Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood 75:203-212
27. Janson RW, Hance KR, Arend WP (1991) Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 147:4218-4223
28. Kasama T, Stricter RM, Standiford TJ, Burdick MD, Kunkel SL (1993) Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J Exp Med 178:63-72
29. Kasinrerk W, Baumruker T, Majdic O, Knapp W, Stockinger H (1993) CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol 150:579-584
30. Kato T, Inaba K, Ogawa Y, Inaba M, Kakihara K, Shimizu S, Ikehara S, Sudo T, Muramatsu S (1990) Granulocyte-macrophage colony-stimulating factor enhances macrophage accessory function in conA-stimulated T-cell proliferation. Cell Immunol 130:490-500
31. Kupper T, Flood P, Coleman D, Horowitz M (1987) Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). J Immunol 138:4288
32. Lieschke GJ, Burgess AW (1992) Drug therapy: granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28-35
33. McColl SR, Paquin R, Menard C, Beaulieu AD (1992) Human neutrophils produce high levels of the interleukin-1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 176:593-598
34. Melani C, Mattia GF, Silvani A, Care A, Rivoltini L, Parmiani G, Colombo MP (1993) Interleukin-6 expression in human neutrophil and cosinophil peripheral blood granulocytes. Blood 81:2744-2749
35. Metcalf D (1993) Hematopoietic regulators: redundancy or subtlety? Blood 82:3515-3523
36. Miyake K, Underhill CB, Lesley J, Kincade PW (1990) Hyaluronate can function as cell adhesion molecule and CD44 participates in hyaluronate receptor. J Exp Med 172:69
37. Molineux G, Migdalska A, Szmitkowski M, Zsebo KM, Dexter TM (1991) The effects of hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961-966
38. Nathan CF (1989) Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73:301-306
39. Ohsaka A, Kitagawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F, Saito M (1989) In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 74:2743
40. Oster W, Brach MA, Gruss HJ, Mertelsmann R, Herrmann F (1992) Interleukin-1 beta (IL-1 beta) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF, and IL-3. Blood 79:1260-1265
41. Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, Kane K, Bentley J, Crowther D (1992) Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood 80:1430-1436
42. Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden R, Platzer E (1991) Neutrophils express the high-affinity receptor for IgG (FcRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:885
43. Rosenthal FM, Cronin K, Bannerji R, Golde DW, Gansbacher B (1994) Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs. Blood 83:1289-1298
44. Santoli D, Clark SC, Kreider BL, Maslin PA, Rovera G (1988) Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor. J Immunol 141:519
45. Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V (1989) Neo-adjuvant chemotherapy for invasive bladder cancer: experience with the M-VAC regimen. Br J Urol 64:250-256
46. Seeber S, Niederle N, Schilcher RB, Schmidt CG (1980) Adriamycin, Cyclophosphamid und Vincristin ("ACO") beim kleinzelligen Bronchialkarzinom. Verlaufsanalyse und Langzeitergebnisse. Onkologie 3:5-11
47. Sieff CA, Emerson SG, Wang EA, Wong GG, Clark SC, Nathan DG (1985) Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. Science 230:1117-1174
48. Silver GM, Gamelli RL, O'Reilly M (1989) The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 106:452-456
49. Spiekermann K, Emmendoerffer A, Eisner J, Raeder E, Lohmann-Matthes M-L, Prahst A, Link H, Freund M, Weite K, Roesler J (1994) Altered surface marker expression and function of G-CSF-induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol 87:31-38
50. Takahashi GW, Andrews DF, Lilly MB, Singer JW, Alderson MR (1993) Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood 81:357-364
51. Tani K, Ozawa K, Ogura H, Takahashi T, Okano A, Watari K, Matsudaira T, Tajika K, Karasuyama H, Nagata S, et al (1989) Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine-supplement gene therapy. Blood 74:1274-1280
52. Tilg H, Mier JW, Vogel W, Aulitzky WE, Wiedermann CJ, Vannier E, Huber C, Dinarello CA (1993) Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol 150:4687-4692
53. Treweeke AT, Aziz KA, Zuzel M (1994) The role of G-CSF in mature neutrophil function is not related to GM-CSF-type cell priming. J Leukoc Biol 55:612-616
54. Ulich TR, del Castillo J, McNiece IK, Yi ES, Alzona CP, Yin S, Zsebo KM (1991) Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo. Blood 78:1954-1962
55. Vadhan-Raj S, Buescher S, LeMaistre A, Keating M, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JU (1988) Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 72:134-141
56. Webb DSA, Shimizu Y, Van Seventer GA, Shaw S, Gerrard TL (1990) LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295
57. Willman CL, Stewart CC, Miller V, Yi TL, Tomasi TB (1989) Regulation of MHC class II gene expression in macrophages by hematopoietic colony-stimulating factors (CSF). Induction by granulocyte/macrophage CSF and inhibition by CSF-1. J Exp Med 170:1559-1567
58. Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F (1989) Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74:2144-2149